Main mode of antineoplastic action is inhibition of DNA synthesis and to a lesser extent that of RNA and protein synthesis. Causes very little bone marrow suppression.
Ademocarcinoma, lymphosarcoma and seminoma. Superficial bladder cancer as a adjuvant in primary or recurrent pterygia.
It is usually administered by parenteral route. It does not cross blood brain barrier.
Haemorrhagic tendencies, bone marrow depression, not to be given I.M. or S.C., thrombocytopenia.
Nausea, vomiting, allergic reactions, fever, anaphylaxis, skin rash, raynaud’s phenomenon, stomatitis, pulmonary fibrosis, hyperpigmentation. Renal and hepatic toxicity.
Lymphoma patients, monitor pulmonary function, anaesthesia.
Terminal elimination half-life 2 - 4 hours.
15mg Injection, single vial per box.
Shree Ganesh
Pharmaceuticals
|
||||||||||||||||||||||||||||||||||||||||||
|
Disclaimer
:
This guide is provided for information purposes only, and for use
of a registered medical practitioner or a hospital or a laboratory only.
The authors, webmaster, or respective references / links are no way
responsible for the content of the information. Although a concerted
effort has been made to ensure the validity of the information contained
in this document, we give no
assurance for the accuracy of the information in this documents. |